BrainZell AB
- Biotech or pharma, therapeutic R&D
BrainZell is re-imaging the way of CNS drug discovery. Our platform powered by iPS cell-derived human brain organoids enables discovery and validation of new drug candidates on real human neural tissue. BrainZell’s technology delivers single organoid precision in unmatched scale of 10 000s of samples.



